Mylan Current Ratio 2006-2018 | MYL

Historical current ratio values for Mylan (MYL) over the last 10 years.
Mylan Annual Current Ratio
2017 1.13
2016 1.49
2015 1.57
2014 1.21
2013 1.51
2012 1.78
2011 1.39
2010 1.97
2009 1.91
2008 2.06
2007 1.53
2007 3.44
2006 4.49
2005 6.23
Mylan Quarterly Current Ratio
Q2 2018 1.30
Q1 2018 1.06
Q4 2017 1.13
Q3 2017 1.46
Q2 2017 1.35
Q1 2017 1.56
Q4 2016 1.49
Q3 2016 0.83
Q2 2016 3.23
Q1 2016 1.67
Q4 2015 1.57
Q3 2015 1.76
Q2 2015 1.47
Q1 2015 1.40
Q4 2014 1.21
Q3 2014 1.30
Q2 2014 1.72
Q1 2014 1.64
Q4 2013 1.51
Q3 2013 1.70
Q2 2013 1.81
Q1 2013 1.73
Q4 2012 1.78
Q3 2012 1.73
Q2 2012 1.73
Q1 2012 1.77
Q4 2011 1.39
Q3 2011 1.52
Q2 2011 1.49
Q1 2011 1.57
Q4 2010 1.97
Q3 2010 2.01
Q2 2010 2.23
Q1 2010 2.05
Q4 2009 1.91
Q3 2009 2.06
Q2 2009 2.13
Q1 2009 2.17
Q4 2008 2.06
Q3 2008 1.88
Q2 2008 1.65
Q1 2008 1.57
Q4 2007 1.53
Q3 2007 3.42
Q2 2007 3.16
Q1 2007 3.44
Q4 2006 4.46
Q3 2006 5.13
Q2 2006 4.41
Q1 2006 0.00
Q4 2005 4.45
Q3 2005 4.70
Q2 2005 5.93
Q1 2005 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $19.669B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $63.001B 10.81
Teva Pharmaceutical Industries (TEVA) Israel $24.629B 6.88
Bausch Health Cos (BHC) Canada $7.633B 5.70
Dr Reddy's Laboratories (RDY) India $5.610B 25.06
Mallinckrodt Public (MNK) United Kingdom $2.887B 4.91
Akorn (AKRX) United States $2.382B 0.00
Supernus Pharmaceuticals (SUPN) United States $2.339B 25.03
Assembly Biosciences (ASMB) United States $0.930B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.824B 118.80
CymaBay Therapeutics (CBAY) United States $0.723B 0.00
Voyager Therapeutics (VYGR) United States $0.626B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.610B 0.00
Homology Medicines (FIXX) United States $0.607B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.589B 0.00
Corium (CORI) United States $0.324B 0.00
Teligent (TLGT) United States $0.228B 0.00
Sol-Gel Technologies (SLGL) Israel $0.119B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.111B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.071B 0.00
Aevi Genomic Medicine (GNMX) United States $0.069B 0.00
Versartis (VSAR) United States $0.065B 0.00
Evoke Pharma (EVOK) United States $0.041B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.020B 0.00
Acasti Pharma (ACST) Canada $0.017B 0.00
Agile Therapeutics (AGRX) United States $0.009B 0.00